Abstract
The global coronary and peripheral stent market size was valued at 5.91 billion USD in 2019 and is projected to reach 8.08 billion USD by 2027 as new and innovative devices are being invented and developed rapidly. In this process of developing new models of stents, one of the key phases is clinical testing on patients. The aim of in silico medicine is to Reduce, Refine and Replace (3R concept) real clinical trials with an aim to decrease costs and time needed to perform a clinical study. Within the InSilc project (funded by H2020 programme, GA 777119) the platform for designing, developing and assessing stents was developed. The platform consists of several modules, some of which can be used as standalone modules. Characteristics of Mechanical and Deployment Module are presented in this chapter. Pricing strategies for different scenarios are described in order to prove the effectiveness and benefits of in-silico testing. The workflow begins from the Mechanical module, and continues to the prediction of the stenting outcomes for different virtual anatomies and different modules: 3D reconstruction and plaque characterization tool, Deployment Module, Fluid dynamics Module, Drug-delivery Module, Degradation Module and Myocardial Perfusion Module. Cost-effectiveness analysis is done using decision tree for in silico and real clinical trials for coronary stent deployment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Learn About Clinical Studies, March 2019. https://clinicaltrials.gov/ct2/about-studies/learn#ClinicalTrials. Accessed 15 Aug 2022
Properzi, F., Taylor, K., Steedman, M.: Intelligent drug discovery, 7 November 2019. https://www2.deloitte.com/us/en/insights/industry/life-sciences/artificial-intelligence-biopharma-intelligent-drug-discovery.html. Accessed 19 Aug 2022
H2020 InSilc project: In-silico trials for drug-eluting BVS design, development and evaluation. https://cordis.europa.eu/project/id/777119. Accessed 19 Aug 2022
Global Balloon-expandable Stents Market – Industry Trends and Forecast to 2028, February 2021. https://www.databridgemarketresearch.com/reports/global-balloon-expandable-stents-market. Accessed 12 Aug 2022
Press Release, February 2021. https://www.databridgemarketresearch.com/press-release. Accessed 21 Aug 2022
Peripheral Vascular Stents Market, July 2021. https://www.futuremarketinsights.com/reports/peripheral-vascular-stents-market. Accessed 5 Aug 2022
Peripheral Vascular Stents Market By Growth, Demand & Opportunities and Forecast to 2028, 7 May 2021. https://www.pharmiweb.com/press-release/2021-05-07/peripheral-vascular-stents-market-by-growth-demand-opportunities-and-forecast-to-2028-medtronic. Accessed 22 Aug 2022
PHARMA.AI. https://insilico.com/platform. Accessed 5 Aug 2022
H2020 DECODE ITN project: Drug-coated balloon simulation and optimization system for the improved treatment of peripheral artery disease, 12 August 2022. https://www.decodeitn.eu/
Fotiadis, D., Filipović, N.: In silico trials for drug-eluting BVS design, development and evaluation. Proj. Repos. J. 8 (2021)
Sox, H.C., Higgins, M.C., Owens, D.K.: Medical Decision Making, 2nd edn. Wiley-Blackwell (2013)
Software PAK. http://www.bioirc.ac.rs/index.php/software/5-pak. Accessed 22 Aug 2022
Hong, M., et al.: Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation (2006)
Saito, N., Mori, Y., Komatsu, T.: Influence of stent flexibility on artery wall stress and wall shear stress in bifurcation lesions, 2 November 2020
Miković, R., et al.: The influence of social capital on knowledge management maturity of non-profit organizations – predictive modelling based on a multilevel analysis. IEEE Access J., 1–15 (2019)
Stefanović, M., et al.: An assessment of maintenance performance indicators using the fuzzy sets approach and genetic algorithms. Part B J. Eng. Manuf. 231, 15–27 (2015)
Acknowledgment
This research is supported by the projects that have received funding from the European Union’s Horizon 2020: InSilc - GA 777119 and DECODE MSCA - GA No 956470. This article reflects only the author's view. The Commission is not responsible for any use that may be made of the information it contains.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Gačić, M. (2023). Cost Effectiveness Analysis of Real and in Silico Clinical Trials for Stent Deployment Based on Decision Tree. In: Filipovic, N. (eds) Applied Artificial Intelligence: Medicine, Biology, Chemistry, Financial, Games, Engineering. AAI 2022. Lecture Notes in Networks and Systems, vol 659. Springer, Cham. https://doi.org/10.1007/978-3-031-29717-5_22
Download citation
DOI: https://doi.org/10.1007/978-3-031-29717-5_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29716-8
Online ISBN: 978-3-031-29717-5
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)
